Chronic spontaneous urticaria: a low-grade disseminated intravascular coagulation only partially reversed by Omalizumab
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1591-9528
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Chronic spontaneous urticaria: a low-grade disseminated intravascular coagulation only partially reversed by Omalizumab ; day:25 ; month:5 ; year:2022 ; pages:1-8
Clinical and experimental medicine ; (25.5.2022), 1-8
- Creator
-
Pino, Marina Di
Ruberto, Maria Filomena
Costanzo, Giulia
Firinu, Davide
Piras, Maria Sebastiana
Mura, Mario Nicola
Giacco, Stefano Del
Coghe, Ferdinando
Marongiu, Francesco
Barcellona, Doris
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10238-022-00838-9
- URN
-
urn:nbn:de:101:1-2022111521010537167453
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pino, Marina Di
- Ruberto, Maria Filomena
- Costanzo, Giulia
- Firinu, Davide
- Piras, Maria Sebastiana
- Mura, Mario Nicola
- Giacco, Stefano Del
- Coghe, Ferdinando
- Marongiu, Francesco
- Barcellona, Doris
- SpringerLink (Online service)
Other Objects (12)
Erfolgreiche Behandlung der Urticaria solaris mit Omalizumab
Omalizumab for chronic urticaria in Latin America
Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
T cell activity in successful treatment of chronic urticaria with omalizumab
Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria
Long term treatment with omalizumab in adolescent with refractory solar urticaria
Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
Real-World Effectiveness of Omalizumab in Chronic Urticaria: A Clinical Observational Study
Inflammatory cytokine levels and changes during omalizumab treatment in chronic spontaneous urticaria
Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
A Case of α-Gal-Unrelated Red Meat-Induced Urticaria Treated by Omalizumab
Erfolgreiche Behandlung der Urticaria solaris mit Omalizumab
Omalizumab for chronic urticaria in Latin America
Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
T cell activity in successful treatment of chronic urticaria with omalizumab
Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria
Long term treatment with omalizumab in adolescent with refractory solar urticaria
Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
Real-World Effectiveness of Omalizumab in Chronic Urticaria: A Clinical Observational Study
Inflammatory cytokine levels and changes during omalizumab treatment in chronic spontaneous urticaria
Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
A Case of α-Gal-Unrelated Red Meat-Induced Urticaria Treated by Omalizumab
Erfolgreiche Behandlung der Urticaria solaris mit Omalizumab
Omalizumab for chronic urticaria in Latin America
Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
T cell activity in successful treatment of chronic urticaria with omalizumab
Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria
Long term treatment with omalizumab in adolescent with refractory solar urticaria
Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
Real-World Effectiveness of Omalizumab in Chronic Urticaria: A Clinical Observational Study
Inflammatory cytokine levels and changes during omalizumab treatment in chronic spontaneous urticaria
Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status